tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Graham Perry, 8 are a BUY (42.11%), 9 are a HOLD (47.37%), 2 are a SELL (10.53%).
Analyst Graham Perry, currently employed at BAML, carries an average stock price target met ratio of 75% that have a potential upside of 49.97% achieved within 2100 days.
Graham Perry’s has documented 29 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 24-Jul-2026.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 10/4/2023. The price target of $118 was fulfilled within 636 days with a profit of $31.31 (36.12%) receiving and performance score of 0.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 10-Sep-2026
$136
$-15.12 (-10.01%)
1 months 15 days ago
(10-Sep-2026)
1/2 (50%)
$-1.48 (-1.08%)
171
Buy Since 26-Mar-2026
$170
$14.59 (9.39%)
6 months 29 days ago
(26-Mar-2026)
10/11 (90.91%)
$20.3 (13.56%)
569
Hold Since 11-Mar-2026
$180
$33.97 (23.26%)
$105
7 months 14 days ago
(11-Mar-2026)
1/2 (50%)
$24.2 (15.53%)
1814
Hold Since 07-Oct-2024
$180
$28.88 (19.11%)
$125
8 months 8 days ago
(17-Feb-2026)
7/8 (87.5%)
$18.74 (11.62%)
1318
Buy Since 11-Sep-2024
$130
8 months 24 days ago
(31-Jan-2026)
2/2 (100%)
$22.14 (20.53%)
548
Which stock is Graham Perry most bullish on?
What Year was the first public recommendation made by Graham Perry?
